1. The potentiation of anti akinetic effect after L-Dopa treatment by an inhibitor of MAO-B, Deprenil;BIRKMAYER, W.; RIEDERER, P.; YOUDIM, M.B.H.; LINAUER, W.;Journal of Neural Transmission,1975
2. Biochemical evidence of adrenergic interaction with cholinergic function in the central nervous system of the rat. 1: effect of norepinephrine;HO, A.K.S.; SINGER, G.; GERSHON, S.;Psychopharmacologia,1971
3. LEES, A.J., KOHOUT, L.J., SHAW, K.M., STERN, G.M., ELSWORTH, J.D., SANDLER, M. & YOUDIM, M.B.H. (1977). Deprenyl in Parkinson's disease. Lancet, [i, 791.
4. In Neurotransmitters and Drugs;PYCOCK, C.J.; KRUK, Z.L.,1979
5. Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinson's disease;RIEDERER, P.; REINOLDS, G.P.;British Journal of Clinical Pharmacology,1980